REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
10.72
-0.56 (-4.96%)
At close: Aug 7, 2026, 4:00 PM EDT
10.76
+0.04 (0.37%)
After-hours: Aug 7, 2026, 7:34 PM EDT
REGENXBIO Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, REGENXBIO stock has a consensus rating of "Buy" and an average price target of $23.1. The average 1-year stock price forecast is 115.49% higher than the current stock price, while the lowest is $10 (-6.72%) and the highest is $50 (+366.42%).
Price Target: $23.1 (+115.49%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for REGENXBIO stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $16 → $18 | Buy | Reiterates | $16 → $18 | +67.91% | Aug 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $19 | Buy | Maintains | $19 | +77.24% | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $14 → $15 | Buy | Reiterates | $14 → $15 | +39.93% | Aug 7, 2026 |
| Barclays | Barclays | Hold Downgrades $12 | Hold | Downgrades | $12 | +11.94% | Aug 7, 2026 |
| Clear Street | Clear Street | Buy Maintains $45 | Buy | Maintains | $45 | +319.78% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
237.89M
from 170.44M
Increased by 39.57%
Revenue Next Year
247.51M
from 237.89M
Increased by 4.05%
EPS This Year
-2.79
from -3.76
EPS Next Year
-2.54
from -2.79
EPS and Forward PE are based on non-GAAP adjusted numbers.